Comparative Study
doi: 10.1007/BF00441128.
Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans
- PMID: 6382015
- DOI: 10.1007/BF00441128
Item in Clipboard
Comparative Study
Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans
Mycopathologia.
.
Abstract
Mice were vaccinated with formalin-killed Cryptococcus neoformans either intranasally, intravenously, or intraperitoneally. Resistance to lethal challenge and in vitro phagocytic activity of alveolar and peritoneal macrophages was studied. Increased resistance to lethal challenge was seen following vaccination by each of the three routes but increased phagocytic activity was seen only in alveolar macrophages from mice vaccinated intranasally.
Similar articles
-
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.mBio. 2015 Dec 22;6(6):e01905-15. doi: 10.1128/mBio.01905-15. mBio. 2015. PMID: 26695631 Free PMC article.
-
Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route--Part II: Phagocytosis and intracellular fate of Cryptococcus neoformans.Mykosen. 1977 Nov;20(11):409-12. Mykosen. 1977. PMID: 339078 No abstract available.
-
Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.Mycopathologia. 1979 Sep 28;68(3):179-81. doi: 10.1007/BF00578527. Mycopathologia. 1979. PMID: 394001
-
Is Development of a Vaccine against Cryptococcus neoformans Feasible?PLoS Pathog. 2015 Jun 18;11(6):e1004843. doi: 10.1371/journal.ppat.1004843. eCollection 2015 Jun. PLoS Pathog. 2015. PMID: 26087178 Free PMC article. Review. No abstract available.
-
Immunity in cryptococcosis: an overview.Mycopathologia. 1982 Mar 19;77(3):183-90. doi: 10.1007/BF00518804. Mycopathologia. 1982. PMID: 7040977 Review.
Cited by
-
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Clin Microbiol Rev. 1995 Oct;8(4):515-48. doi: 10.1128/CMR.8.4.515. Clin Microbiol Rev. 1995. PMID: 8665468 Free PMC article. Review.
-
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.mBio. 2015 Dec 22;6(6):e01905-15. doi: 10.1128/mBio.01905-15. mBio. 2015. PMID: 26695631 Free PMC article.
-
CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract.J Exp Med. 1992 Jun 1;175(6):1685-95. doi: 10.1084/jem.175.6.1685. J Exp Med. 1992. PMID: 1588288 Free PMC article.
-
Killed Saccharomyces cerevisiae protects against lethal challenge of Cryptococcus grubii.Mycopathologia. 2014 Oct;178(3-4):189-95. doi: 10.1007/s11046-014-9798-5. Epub 2014 Aug 15. Mycopathologia. 2014. PMID: 25118873
-
Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells.Infect Immun. 1994 Aug;62(8):3189-96. doi: 10.1128/iai.62.8.3189-3196.1994. Infect Immun. 1994. PMID: 8039888 Free PMC article.